OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AUTL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUTL is expected to report earnings to fall 11.58% to -22 cents per share on August 12

Autolus Therapeutics AUTL Stock Earnings Reports

Q2'25

Est.

$-0.23

Q1'25

Est.

$-0.26

Q4'24

Beat

by $0.12

Q3'24

Missed

by $0.10

Q2'24

Missed

by $0.03

The last earnings report on May 08 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 713.19K shares outstanding, the current market capitalization sits at 614.78M.

View a ticker or compare two or three

Compare

AUTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AUTL
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUTL showed earnings on May 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

191 Wood Lane

Phone

+44 2038296230

Employees

471

Web

https://www.autolus.com